Crunchbase reports global venture capital was flat in April
Nearly one-half of the funds invested for the month - just over $22 billion - went to Series C or even later stage companies.
Gené Teare writes in this Crunchbase News article that global venture capital funding reached just over $22 billion in April 2024 — flat month-over-month and up a few percentage points year-over-year.
“The slowdown in venture funding has continued despite the AI (artificial intelligence) technology wave that has washed over start-ups in the past few years,” she notes, adding that the breakdown was as follows:
- Roughly $2.4 billion, or 11 percent of the $22 billion, went to about 1,000 seed stage companies;
- Another $9 billion went to those classified as early stage companies; and
- The balance – $10.7 billion or nearly one-half of the funds invested, went to Series C or even later stage companies.
“Biotech and healthcare was the leading sector by funding amount in April,” Teare wrote. “Companies in that space raised $5.7 billion, or around 26 percent of all funding, according to Crunchbase data. AI companies raised $3.9 billion, or about 17 percent of funding last month.
